scispace - formally typeset
Journal ArticleDOI

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.

Reads0
Chats0
TLDR
The glycine agonist (D-cycloserine) potentiated the effects of the non-competitive but antagonized those of the competitive NMDA antagonist, which reduced neuroleptic-induced catalepsy and locomotion.
Abstract
The effects of competitive (CGP 37849 and CGP 39551) and non-competitive (dizocilpine) N-methyl-D-aspartate (NMDA) antagonists were tested in three animal models (catalepsy, sniffing, locomotion) and, in addition, the modulation of these effects by an agonist of the strychnine-insensitive glycine binding site was investigated. Both competitive and non-competitive NMDA antagonists reduced neuroleptic-induced catalepsy. Weak sniffing was induced by the competitive antagonist but strong sniffing by the non-competitive NMDA antagonist. Due to muscle relaxation the competitive antagonist reduced locomotion, in contrast to stimulation of locomotor activity induced by the non-competitive NMDA antagonist. The glycine agonist (D-cycloserine) potentiated the effects of the non-competitive but antagonized those of the competitive NMDA antagonist.

read more

Citations
More filters
Journal ArticleDOI

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors

TL;DR: The results indicate that the reversible atrophy induced by 21 days of daily restraint stress requires corticosterone secretion and that excitatory mechanisms involving N-methyl-D-aspartate receptors play a major role in driving the atrophy.
Journal Article

Glycine and N-Methyl-d-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications

TL;DR: It is shown that glycine enhances electrophysiological responses mediated by N-methyl-d-aspartate (NMDA)b-sensitive glutamatergic receptors through its role as a “spatially aggregating substance” to NMDA receptors.
Journal Article

Characterization of MK-801-Induced Behavior as a Putative Rat Model of Psychosis

TL;DR: MK-801-induced behavior represents a rat excitatory amino acid hypofunction model of psychosis that appears to be of clinical relevance and may be of value in the search for new antipsychotic agents.
Journal ArticleDOI

Glutamate receptors as therapeutic targets for Parkinson's disease.

TL;DR: Glutamate receptors represent exciting targets for the development of novel pharmacological therapies for PD as modulating the activity of these receptors may alleviate the primary motor symptoms of PD as well as side effects induced by dopamine replacement therapy.
Journal ArticleDOI

MK-801 prevents the development of behavioral sensitization during repeated morphine administration.

TL;DR: A complex interplay between NMDA and opioid receptors is suggested, such that NMDA antagonists prevent morphine sensitization while morphine enhances the ability ofNMDA antagonists to elicit sensitization to their own locomotor stimulatory effects.
References
More filters
Journal ArticleDOI

Effects of D-cycloserine and cycloleucine, ligands for the NMDA-associated strychnine-insensitive glycine site, on brain-stimulation reward and spontaneous locomotion.

TL;DR: In the present study, DCS failed to affect spontaneous locomotor activity or variable-interval self-stimulation response rate, and improvements in learning and retention reported after administration are unlikely to be accounted for by nonassociative motivational, or performance, factors.
Book ChapterDOI

Cerebroprotective and anticonvulsant action of competitive and non-competitive NMDA antagonists

TL;DR: Both competitive and non-competitive NMDA antagonists have cerebroprotective activity in a number of ischemia, hypoxia and trauma models, as well as anticonvulsant activity ina wide range of animal seizure models, and correlate well with their affinities for the NMDA receptor.
Related Papers (5)